Abstract
Stent strut fracture (SSF) after drug-eluting stent (DES) implantation may be an important complication after DES implantation particularly in patients undergoing sirolimus eluting stent implantation. Since SSF is a highly relevant adverse event which can result in in-stent restenosis and thrombosis, we believe that DES with flexible stent platform or biodegradable DES may be needed to prevent this potential catastrophic complication.
MeSH terms
-
Coronary Restenosis / etiology*
-
Coronary Restenosis / prevention & control
-
Drug-Eluting Stents / adverse effects*
-
Drug-Eluting Stents / classification
-
Drug-Eluting Stents / standards
-
Equipment Failure
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Incidence
-
Risk Factors
-
Sirolimus / administration & dosage
-
Thrombosis / etiology*
-
Thrombosis / prevention & control
-
Treatment Failure
Substances
-
Immunosuppressive Agents
-
Sirolimus